Lipid droplet accumulation in β cells in patients with type 2 diabetes is associated with insulin resistance, hyperglycemia and β cell dysfunction involving decreased insulin granules

Front Endocrinol (Lausanne). 2022 Sep 20:13:996716. doi: 10.3389/fendo.2022.996716. eCollection 2022.

Abstract

Background and objective: Pancreatic fat is a form of ectopic fat. Lipid droplets (LDs) are also observed in β cells; however, the pathophysiological significance, especially for β cell function, has not been elucidated. Our aim was to assess LD accumulation in β cells in various stages of glucose intolerance and to clarify its relationship with clinical and histological parameters.

Methods: We examined 42 Japanese patients who underwent pancreatectomy. The BODIPY493/503-positive (BODIPY-positive) area in β cells was measured in pancreatic sections from 32 patients. The insulin granule numbers were counted in an additional 10 patients using electron microscopy.

Results: The BODIPY-positive area in β cells in preexisting type 2 diabetes patients was higher than that in normal glucose tolerance patients (p = 0.031). The BODIPY-positive area in β cells was positively correlated with age (r = 0.45, p = 0.0097), HbA1c (r = 0.38, p = 0.0302), fasting plasma glucose (r = 0.37, p = 0.045), and homeostasis model assessment insulin resistance (r = 0.41, p = 0.049) and negatively correlated with an increase in the C-peptide immunoreactivity level by the glucagon test (r = -0.59, p = 0.018). The ratio of mature insulin granule number to total insulin granule number was reduced in the patients with rich LD accumulation in β cells (p = 0.039).

Conclusions: Type 2 diabetes patients had high LD accumulation in β cells, which was associated with insulin resistance, hyperglycemia, aging and β cell dysfunction involving decreased mature insulin granules.

Keywords: Pancreatic fat; Type 2 diabetes; ectopic fat; lipid droplets; β cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose / metabolism
  • Boron Compounds
  • C-Peptide
  • Diabetes Mellitus, Type 2* / metabolism
  • Glucagon
  • Glucose Tolerance Test
  • Glycated Hemoglobin
  • Humans
  • Hyperglycemia*
  • Insulin / metabolism
  • Insulin Resistance*
  • Lipid Droplets / metabolism

Substances

  • 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
  • Blood Glucose
  • Boron Compounds
  • C-Peptide
  • Glycated Hemoglobin A
  • Insulin
  • Glucagon